Cambridge, MA, United States of America

Paul Konowicz


 

Average Co-Inventor Count = 11.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Bridgewater, NJ (US) (2020)
  • Cambridge, MA (US) (2020 - 2021)

Company Filing History:


Years Active: 2020-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Paul Konowicz: Innovator in GLP-1/Glucagon Dual Agonist Research

Introduction

Paul Konowicz is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of GLP-1/Glucagon dual agonists. With a total of three patents to his name, Konowicz is recognized for his innovative approaches to treating various diseases and disorders.

Latest Patents

Konowicz's latest patents include groundbreaking inventions that focus on conjugates and prodrugs involving GLP-1/Glucagon receptor agonists. One of his patents describes a conjugate comprising a GLP-1/Glucagon dual agonist, a linker, and hyaluronic acid. This invention aims to create a pharmaceutical composition that can be used as a medicament for treating or preventing diseases that can be addressed by GLP-1/Glucagon receptor agonists. Another patent details a prodrug that includes a GLP-1/Glucagon agonist linker conjugate, which also serves as a potential treatment for similar medical conditions.

Career Highlights

Paul Konowicz is currently employed at Sanofi, a global healthcare company. His work at Sanofi has allowed him to focus on innovative research and development in the pharmaceutical sector. His contributions have been instrumental in advancing the understanding and application of GLP-1/Glucagon dual agonists.

Collaborations

Throughout his career, Konowicz has collaborated with esteemed colleagues, including Dieter Kadereit and Michael Wagner. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their shared field of research.

Conclusion

Paul Konowicz is a prominent inventor whose work in GLP-1/Glucagon dual agonists has the potential to impact the treatment of various medical conditions. His patents and collaborations reflect his commitment to advancing pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…